colchicine has been researched along with Neointima in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Strauss, BH | 1 |
Alexopoulos, D; Cleman, MW; Deftereos, S; Driva, M; Giannopoulos, G; Hahalis, G; Kaoukis, A; Kossyvakis, C; Manolis, AS; Panagopoulou, V; Pyrgakis, V; Raisakis, K; Stefanadis, C | 1 |
Deng, Y; Dong, Q; Kong, J; Liu, W; Lu, Y | 1 |
1 trial(s) available for colchicine and Neointima
Article | Year |
---|---|
Colchicine treatment for the prevention of bare-metal stent restenosis in diabetic patients.
Topics: Adult; Aged; Aged, 80 and over; Colchicine; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Male; Middle Aged; Neointima; Percutaneous Coronary Intervention; Prospective Studies; Stents; Treatment Outcome | 2013 |
2 other study(ies) available for colchicine and Neointima
Article | Year |
---|---|
Diabetic patients receiving bare-metal stents: no option patients?
Topics: Colchicine; Coronary Restenosis; Coronary Vessels; Diabetes Mellitus, Type 2; Female; Humans; Male; Neointima; Percutaneous Coronary Intervention; Stents | 2013 |
Colchicine reduces restenosis after balloon angioplasty treatment for in-stent restenosis.
Topics: Angioplasty, Balloon, Coronary; Animals; Colchicine; Combined Modality Therapy; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Muscle, Smooth, Vascular; Neointima; Paclitaxel; Proliferating Cell Nuclear Antigen; Random Allocation; Swine; Swine, Miniature; Treatment Outcome | 2015 |